FAM26E Inhibitors
Chemical inhibitors of FAM26E function by targeting various signaling pathways and kinases that are involved in the phosphorylation and regulation of this protein's activity. Staurosporine serves as a broad-spectrum kinase inhibitor, which means it can inhibit a wide range of kinases that are responsible for the phosphorylation of FAM26E, leading to its inhibition. LY294002 and Wortmannin specifically inhibit phosphoinositide 3-kinases (PI3K), which are known to be involved in several cellular processes, including those that may regulate FAM26E. By inhibiting PI3K, these chemicals prevent the activation of downstream targets that could otherwise contribute to the functional activity of FAM26E.
Moreover, U0126 and PD98059 target the MEK1/2 enzymes, which are upstream regulators of the ERK pathways. These pathways can be directly involved in phosphorylating FAM26E, and their inhibition by U0126 and PD98059 prevents the activation of ERK and potentially other kinases involved in controlling FAM26E function. Similarly, SB203580 acts on the p38 MAP kinase, which is implicated in the cellular stress response, and by inhibiting it, SB203580 can impede phosphorylation events necessary for FAM26E's activity. SP600125 inhibits the c-Jun N-terminal kinase (JNK) pathway, which might be involved in the activation of FAM26E, leading to its inhibition. Rapamycin, by inhibiting the mTOR pathway, disrupts central cell growth signaling cascades, which may also involve FAM26E. PP2 inhibits Src family tyrosine kinases, which if involved in phosphorylating FAM26E, would result in its direct inhibition. Lastly, Bisindolylmaleimide I and Gö 6983 are potent inhibitors of protein kinase C (PKC), and their inhibition of PKC could result in the functional inhibition of FAM26E. K252a also targets protein kinases like PKC, PKA, and PKG, which if involved in FAM26E regulation, will be inhibited, leading to decreased FAM26E activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a broad-spectrum kinase inhibitor, Staurosporine can inhibit kinases that phosphorylate FAM26E, thereby inhibiting its activation and function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases which may be involved in the phosphorylation cascade that regulates FAM26E activity. By inhibiting PI3K, LY294002 prevents the activation of downstream targets that could lead to the functional inhibition of FAM26E. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another inhibitor of phosphoinositide 3-kinases which could play a role in the activity of FAM26E. By inhibiting PI3K, Wortmannin blocks the downstream signaling necessary for FAM26E function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 selectively inhibits MEK1/2, which are upstream regulators of ERK pathways that could be phosphorylating FAM26E. Inhibition of MEK1/2 by U0126 would inhibit the activation of ERK and potentially other kinases involved in FAM26E function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that prevents the activation of MAPK/ERK pathway, which may be implicated in the regulation of FAM26E. Inhibition of this pathway by PD98059 would lead to functional inhibition of FAM26E. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, potentially involved in stress response pathways that could regulate FAM26E. By inhibiting p38 MAP kinase, SB203580 could impede any phosphorylation events necessary for FAM26E's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits the c-Jun N-terminal kinase (JNK) pathway. JNK may be involved in the activation of FAM26E, and its inhibition by SP600125 could lead to the functional inhibition of FAM26E. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is central to cell growth and may interact with FAM26E. By inhibiting mTOR, Rapamycin may indirectly inhibit the functional activity of FAM26E by disrupting signaling cascades that FAM26E is involved in. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases which could be responsible for phosphorylation events that activate FAM26E. By inhibiting these kinases, PP2 could directly inhibit the functional activity of FAM26E. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I inhibits protein kinase C (PKC). Since PKC may be involved in signaling pathways regulating FAM26E, inhibition of PKC by Bisindolylmaleimide I could result in the functional inhibition of FAM26E. | ||||||